Resolution of bisphosphonate-associated osteonecrosis of the mandible: possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]

J Oral Maxillofac Surg. 2007 Mar;65(3):573-80. doi: 10.1016/j.joms.2006.10.076.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Alendronate / adverse effects*
  • Bone Density Conservation Agents / administration & dosage*
  • Bone Density Conservation Agents / adverse effects*
  • Clinical Protocols
  • Female
  • Humans
  • Injections, Subcutaneous
  • Mandibular Diseases / chemically induced
  • Mandibular Diseases / drug therapy*
  • Osteonecrosis / chemically induced
  • Osteonecrosis / drug therapy*
  • Teriparatide / administration & dosage*
  • Tooth Extraction / adverse effects

Substances

  • Bone Density Conservation Agents
  • Teriparatide
  • Alendronate